June 30, 2014

Afrezza, an inhaled insulin powder meant to treat diabetes patients, was approved Friday by the Food and Drug Administration.

September 30, 2011

Novo Nordisk is seeking approval for two new insulin products, the company said Thursday.

July 6, 2011

Patients with Type 1 diabetes using an insulin product made by MannKind expressed a better opinion about insulin therapy than those taking the standard treatment, according to a study presented at the American Diabetes Association’s 71st Scientific Sessions.

January 20, 2011

It seems that MannKind has experienced a setback with a drug designed to control hyperglycemia in Type 1 and Type 2 diabetes patients.

January 3, 2011

This past year saw a lower-than-usual number of new drugs approved by the Food and Drug Administration, due in part to delays at the agency, according to published reports.

June 24, 2010

An inhaled insulin made by MannKind for patients with Type 2 diabetes provides glycemic control...

March 15, 2010

The Food and Drug Administration did not approve an application from MannKind Corp. for a...